Keynote speakers

We are pleased to announce the following Keynote speakers

CSC P J Devereaux 400x300

Professor P.J Devereaux

Professor Devereaux is the Director of the Division of Cardiology at McMaster University.

He is also the Scientific Leader of the Anesthesiology, Perioperative Medicine, and Surgical Research Group at the Population Health Research Institute. Devereaux is a full Professor and University Scholar in the Departments of Health Research Methods, Evidence, and Impact (HEI) and Medicine at McMaster University.

The focus of his clinic research is vascular complications around the time of surgery. He is undertaking several large international RCTs and observational studies addressing this issue. He has published more than 250 peer reviewed papers and 50 book chapters and editorials. He is supported by a Tier 1 Canadian Research Chair in Perioperative Medicine, and he holds the Yusuf Chair in Cardiology at McMaster University.

CSC22 Kate Leslie 400x300

Professor Kate Leslie - Australasian Invited speaker

Professor Leslie is a specialist anaesthetist and head of research in the Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, and honorary professorial fellow at the University of Melbourne and Monash University.

Kate is a former ANZCA president and is currently the president of the Australian Medical Council, the accreditation authority for medicine in Australia. Kate is a foundation member of the ANZCA Clinical Trials Network and was the chair between 2014-7.

Her current research interests include perioperative clinical trials and sex/gender equity in research and practice. She is also an editor of Miller’s Anesthesia textbook, the British Journal of Anaesthesia, Anesthesiology and Anesthesia and Analgesia.

CSC22 Denny Levett 400x300

Professor Denny Levett

Professor Levett is a Professor in Perioperative Medicine and Critical Care at the University of Southampton and a Consultant in Perioperative Medicine at Southampton University Hospital NHS Foundation trust (UHS).

Denny leads the perioperative medicine service at UHS including a pre-operative CPET service, a pre-operative anaemia service, a surgery school, a shared decision-making clinic and prehabilitation. Her clinical and research interests explore the role of exercise in pre-operative risk stratification and pre-operative optimisation to improve surgical outcomes. She is president of the Perioperative Exercise Testing and Training Society (POETTS) ( and established and chairs the National Perioperative Cardiopulmonary Exercise Testing course. She is part of the Fit 4 Surgery research group in Southampton, investigating exercise, psychological and nutritional prehabilitation and is the clinical lead for the multi-centre Wesfit Trial. She is the clinical CI for the INSPIRE trial evaluating inspiratory muscle training before surgery as a means of reducing post-operative complications.

Denny was the research leader, the expedition medical officer and a member of the climbing team on the Caudwell Xtreme Everest Research Expedition, a high-altitude field study of hypoxia adaptation. Her PhD thesis involved evaluating exercise capacity at up to 8000m on Mount Everest. (

CSC22 Steven Shafer 400x300

Professor Steven Shafer

Professor Shafer is Professor of Anesthesiology, Perioperative and Pain Medicine (Adult MSD) at the Stanford University Medical Centre.

His professional interests are the clinical pharmacology of intravenous anesthetic drugs. This has led him to clinical studies of many of the intravenous opioids and hypnotics used in anesthetic practice.

However, his passion is not the drugs themselves, but rather the mathematical models that characterise drug behaviour. These include conventional pharmacokinetic and pharmacodynamic models, inverse models (used to drive target-controlled infusion systems), Bayesian models (used to handle model uncertainty), pharmacokinetic and pharmacodynamic models of drug interaction, models of receptor function that help elucidate mechanisms of drug action, and models that relate drug response to 'in silico' pharmacogenetics.